CompletedNot Applicable

Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East

Kuwait104 participantsStarted 2020-03-01

Plain-language summary

Methods: Out of 2000 kidney transplant recipients in our center in Kuwait, collecting data was started for all COVID-19-positive kidney transplant recipients till August 2020. Clinical features, management details and both patient and graft outcomes were reported.

Who can participate

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All renal transplant patients infected with COVID-19 during the period of 6 months from 3.2020 till the end of 8.2020 Exclusion Criteria: * Pediatric patients

What they're measuring

patient outcome

Timeframe: 30 days

Kidney graft outcome

Timeframe: 30 days

Trial details

NCT IDNCT04542954

SponsorHamid Al-Essa Organ Transplant Center

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2020-08-31

View on ClinicalTrials.gov More Covid19 trials